223 related articles for article (PubMed ID: 15322211)
1. n-Nonanoyl-CC chemokine ligand 14, a potent CC chemokine ligand 14 analogue that prevents the recruitment of eosinophils in allergic airway inflammation.
Forssmann U; Hartung I; Bälder R; Fuchs B; Escher SE; Spodsberg N; Dulkys Y; Walden M; Heitland A; Braun A; Forssmann WG; Elsner J
J Immunol; 2004 Sep; 173(5):3456-66. PubMed ID: 15322211
[TBL] [Abstract][Full Text] [Related]
2. The allergy-associated chemokine receptors CCR3 and CCR5 can be inactivated by the modified chemokine NNY-CCL11.
Manns J; Rieder S; Escher S; Eilers B; Forssmann WG; Elsner J; Forssmann U
Allergy; 2007 Jan; 62(1):17-24. PubMed ID: 17156337
[TBL] [Abstract][Full Text] [Related]
3. n-Nonanoyl-CCL14 (NNY-CCL14), a novel inhibitor of allergic airway inflammation is a partial agonist of human CCR2.
Gupta S; Erdmann G; Schulz-Maronde S; Escher SE; Richter R; Forssmann WG; Elsner J; Forssmann U
Allergy; 2008 Oct; 63(10):1317-23. PubMed ID: 18782110
[TBL] [Abstract][Full Text] [Related]
4. Intravascular inactivation of CCR5 by n-Nonanoyl-CC chemokine ligand 14 and inhibition of allergic airway inflammation.
Gupta S; Fuchs B; Schulz-Maronde S; Heitland A; Escher SE; Mack M; Tillmann HC; Braun A; Forssmann WG; Elsner J; Forssmann U
J Leukoc Biol; 2008 Mar; 83(3):765-73. PubMed ID: 18063698
[TBL] [Abstract][Full Text] [Related]
5. CCR1- and CCR5-mediated inactivation of leukocytes by a nonglycosaminoglycan (non-GAG)-binding variant of n-nonanoyl-CCL14 (NNY-CCL14).
Gupta S; Rieder S; Richter R; Schulz-Maronde S; Manns J; Escher SE; Heitland A; Mack M; Forssmann WG; Elsner J; Forssmann U
J Leukoc Biol; 2010 Aug; 88(2):383-92. PubMed ID: 20483925
[TBL] [Abstract][Full Text] [Related]
6. A central regulatory role for eosinophils and the eotaxin/CCR3 axis in chronic experimental allergic airway inflammation.
Fulkerson PC; Fischetti CA; McBride ML; Hassman LM; Hogan SP; Rothenberg ME
Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16418-23. PubMed ID: 17060636
[TBL] [Abstract][Full Text] [Related]
7. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
Morokata T; Suzuki K; Masunaga Y; Taguchi K; Morihira K; Sato I; Fujii M; Takizawa S; Torii Y; Yamamoto N; Kaneko M; Yamada T; Takahashi K; Shimizu Y
J Pharmacol Exp Ther; 2006 Apr; 317(1):244-50. PubMed ID: 16339911
[TBL] [Abstract][Full Text] [Related]
8. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils.
White JR; Imburgia C; Dul E; Appelbaum E; O'Donnell K; O'Shannessy DJ; Brawner M; Fornwald J; Adamou J; Elshourbagy NA; Kaiser K; Foley JJ; Schmidt DB; Johanson K; Macphee C; Moores K; McNulty D; Scott GF; Schleimer RP; Sarau HM
J Leukoc Biol; 1997 Nov; 62(5):667-75. PubMed ID: 9365122
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of airway inflammation by amino-terminally modified RANTES/CC chemokine ligand 5 analogues is not mediated through CCR3.
Chvatchko Y; Proudfoot AE; Buser R; Juillard P; Alouani S; Kosco-Vilbois M; Coyle AJ; Nibbs RJ; Graham G; Offord RE; Wells TN
J Immunol; 2003 Nov; 171(10):5498-506. PubMed ID: 14607956
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of eosinophil influx into the lung by small molecule CC chemokine receptor 3 antagonists in mouse models of allergic inflammation.
Das AM; Vaddi KG; Solomon KA; Krauthauser C; Jiang X; McIntyre KW; Yang XX; Wadman E; Welch P; Covington M; Graden D; Yeleswaram K; Trzaskos JM; Newton RC; Mandlekar S; Ko SS; Carter PH; Davies P
J Pharmacol Exp Ther; 2006 Jul; 318(1):411-7. PubMed ID: 16614169
[TBL] [Abstract][Full Text] [Related]
11. C-C chemokine receptor 3 antagonism by the beta-chemokine macrophage inflammatory protein 4, a property strongly enhanced by an amino-terminal alanine-methionine swap.
Nibbs RJ; Salcedo TW; Campbell JD; Yao XT; Li Y; Nardelli B; Olsen HS; Morris TS; Proudfoot AE; Patel VP; Graham GJ
J Immunol; 2000 Feb; 164(3):1488-97. PubMed ID: 10640766
[TBL] [Abstract][Full Text] [Related]
12. Functional expression and characterization of macaque C-C chemokine receptor 3 (CCR3) and generation of potent antagonistic anti-macaque CCR3 monoclonal antibodies.
Zhang L; Soares MP; Guan Y; Matheravidathu S; Wnek R; Johnson KE; Meisher A; Iliff SA; Mudgett JS; Springer MS; Daugherty BL
J Biol Chem; 2002 Sep; 277(37):33799-810. PubMed ID: 12101185
[TBL] [Abstract][Full Text] [Related]
13. Temporal production of CCL28 corresponds to eosinophil accumulation and airway hyperreactivity in allergic airway inflammation.
John AE; Thomas MS; Berlin AA; Lukacs NW
Am J Pathol; 2005 Feb; 166(2):345-53. PubMed ID: 15681819
[TBL] [Abstract][Full Text] [Related]
14. Differential activation of CC chemokine receptors by AOP-RANTES.
Elsner J; Mack M; Brühl H; Dulkys Y; Kimmig D; Simmons G; Clapham PR; Schlöndorff D; Kapp A; Wells TN; Proudfoot AE
J Biol Chem; 2000 Mar; 275(11):7787-94. PubMed ID: 10713092
[TBL] [Abstract][Full Text] [Related]
15. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody.
Heath H; Qin S; Rao P; Wu L; LaRosa G; Kassam N; Ponath PD; Mackay CR
J Clin Invest; 1997 Jan; 99(2):178-84. PubMed ID: 9005985
[TBL] [Abstract][Full Text] [Related]
16. Regulation of chemokine receptor expression in eosinophils.
Nagase H; Miyamasu M; Yamaguchi M; Fujisawa T; Kawasaki H; Ohta K; Yamamoto K; Morita Y; Hirai K
Int Arch Allergy Immunol; 2001; 125 Suppl 1():29-32. PubMed ID: 11408769
[TBL] [Abstract][Full Text] [Related]
17. The CCR3 receptor is involved in eosinophil differentiation and is up-regulated by Th2 cytokines in CD34+ progenitor cells.
Lamkhioued B; Abdelilah SG; Hamid Q; Mansour N; Delespesse G; Renzi PM
J Immunol; 2003 Jan; 170(1):537-47. PubMed ID: 12496441
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of CD26/dipeptidyl peptidase IV enhances CCL11/eotaxin-mediated recruitment of eosinophils in vivo.
Forssmann U; Stoetzer C; Stephan M; Kruschinski C; Skripuletz T; Schade J; Schmiedl A; Pabst R; Wagner L; Hoffmann T; Kehlen A; Escher SE; Forssmann WG; Elsner J; von Hörsten S
J Immunol; 2008 Jul; 181(2):1120-7. PubMed ID: 18606664
[TBL] [Abstract][Full Text] [Related]
19. Aminooxypentane-RANTES induces CCR3 activation and internalization of CCR3 from the surface of human eosinophils.
Elsner J; Dulkys Y; Kimmig D; Wells TN; Proudfoot AE; Kapp A
Int Arch Allergy Immunol; 2001; 124(1-3):227-9. PubMed ID: 11306977
[TBL] [Abstract][Full Text] [Related]
20. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES).
Ying S; Robinson DS; Meng Q; Barata LT; McEuen AR; Buckley MG; Walls AF; Askenase PW; Kay AB
J Immunol; 1999 Oct; 163(7):3976-84. PubMed ID: 10491000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]